The Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy
Ji Won Lim, Su Jeong Ryu, Min Cheol Shin
Korean J Ophthalmol. 2010;24(3):155-158.   Published online 2010 Jun 5     DOI: https://doi.org/10.3341/kjo.2010.24.3.155
Citations to this article as recorded by Crossref logo
Actualización en el tratamiento de la coriorretinopatía serosa central crónica
F.J. Moreno-Morillo, J.I. Fernández-Vigo, N. Güemes-Villahoz, B. Burgos-Blasco, L. López-Guajardo, J. Donate-López
Archivos de la Sociedad Española de Oftalmología.2020;[Epub]     CrossRef
Current Pharmacological Treatment Options for Central Serous Chorioretinopathy: A Review
Massimo Nicolò, Lorenzo Ferro Desideri, Aldo Vagge, Carlo Enrico Traverso
Pharmaceuticals.2020; 13(10): 264.     CrossRef
Long-term treatment response after intravitreal bevacizumab injections for patients with central serous chorioretinopathy
Hae Min Kang, Jeong Hoon Choi, Hyoung Jun Koh, Sung Chul Lee, Demetrios G. Vavvas
PLOS ONE.2020; 15(9): e0238725.     CrossRef
Update on the management of chronic central serous chorioretinopathy
F.J. Moreno-Morillo, J.I. Fernández-Vigo, N. Güemes-Villahoz, B. Burgos-Blasco, L. López-Guajardo, J. Donate-López
Archivos de la Sociedad Española de Oftalmología (English Edition).2020;[Epub]     CrossRef
Long-term visual and anatomic outcomes of patients with peripapillary pachychoroid syndrome
David Xu, Elisha Garg, Kook Lee, Yoichi Sakurada, Atchara Amphornphruet, Nopasak Phasukkijwatana, Sandra Liakopoulos, Scott Eugene Pautler, Allan E Kreiger, Suzanne Yzer, Won Ki Lee, SriniVas Sadda, K Bailey Freund, David Sarraf
British Journal of Ophthalmology.2020; : bjophthalmol-2019-315550.     CrossRef
TWELVE-MONTH EFFICACY OF INTRAVITREAL BEVACIZUMAB INJECTION FOR CHRONIC, ATYPICAL, OR RECURRENT CENTRAL SEROUS CHORIORETINOPATHY
Yoo-Ri Chung, Jong Wan Kim, Ji Hun Song, Aram Park, Min Ho Kim
Retina.2019; 39(1): 134.     CrossRef
Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy
Sibel Demirel, Gökçen Özcan, Özge Yanık, Figen Batıoğlu, Emin Özmert
Graefe's Archive for Clinical and Experimental Ophthalmology.2019; 257(5): 905.     CrossRef
Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years
Yang Jae Kim, Si Yeol Kim, Seungmin Ha, Daruchi Moon, San Seong, Oh Woong Kwon, Han Sang Park
Eye.2019; 33(5): 819.     CrossRef
Pharmacotherapy of Central Serous Chorioretinopathy: A Review of the Current Treatments
Pierluigi Iacono, Lisa Toto, Eliana Costanzo, Monica Varano, Maria Cristina Parravano
Current Pharmaceutical Design.2019; 24(41): 4864.     CrossRef
Central serous chorioretinopathy and glucocorticoids: an update on evidence for association
Benjamin P. Nicholson, Elizabeth Atchison, Amrou Ali Idris, Sophie J. Bakri
Survey of Ophthalmology.2018; 63(1): 1.     CrossRef
Treatment of Central Serous Chorioretinopathy (Csc) Using Diclofenac through Different Routes of Administration, a Comparative Study
Nisar Ahmed Khan
Advances in Ophthalmology & Visual System.2017;[Epub]     CrossRef
Diagnosed a Patient with Central Serous Chorioretinopathy? Now What?: Management of Central Serous Chorioretinopathy
Brian E. Goldhagen, Raquel Goldhardt
Current Ophthalmology Reports.2017; 5(2): 141.     CrossRef
Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser
Maciej Gawęcki, Agnieszka Jaszczuk-Maciejewska, Anna Jurska-Jaśko, Andrzej Grzybowski
Graefe's Archive for Clinical and Experimental Ophthalmology.2017; 255(12): 2299.     CrossRef
Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis
Shangli Ji, Yemei Wei, Jiansu Chen, Shibo Tang
International Journal of Clinical Pharmacy.2017; 39(3): 514.     CrossRef
Topical Bromfenac in the Treatment of Central Serous Chorioretinopathy
Nisar Ahmed Khan
Advances in Ophthalmology & Visual System.2017;[Epub]     CrossRef
Exudative retinal detachment
Radgonde Amer, Hilal Nalcı, Nilüfer Yalçındağ
Survey of Ophthalmology.2017; 62(6): 723.     CrossRef
Efficacy of Intravitreal Bevacizumab for Recurrent Central Serous Chorioretinopathy in Patients Who Had Previously Responded Well to the Same Therapy
Kyung-Hoon Shin, Jae Hui Kim, Sung Won Cho, Tae Gon Lee, Chul Gu Kim, Jong Woo Kim
Journal of Ocular Pharmacology and Therapeutics.2016; 32(7): 425.     CrossRef
Bilateral Central Scotoma Due to CSCR in an Asthmatic Policeman
Lai Chan Fhun, Evelyn Tai Li Min, Mei Fong Chong, Ahmad Tajudin Liza-Sharmini
Open Journal of Ophthalmology.2016; 06(04): 240.     CrossRef
Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy
Emin Özmert, Sibel Demirel, Özge Yanık, Figen Batıoğlu
Journal of Ophthalmology.2016; 2016: 1.     CrossRef
Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis
H Q Lu, E Q Wang, T Zhang, Y X Chen
Eye.2016; 30(1): 15.     CrossRef
Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients
G A Kim, T H Rim, S C Lee, S H Byeon, H J Koh, S S Kim, C S Lee
Eye.2015; 29(6): 732.     CrossRef
Interventions for central serous chorioretinopathy: a network meta-analysis
Mahsa Salehi, Adam S Wenick, Hua Andrew Law, Jennifer R Evans, Peter Gehlbach
Cochrane Database of Systematic Reviews.2015;[Epub]     CrossRef
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis
Alejandra Daruich, Alexandre Matet, Ali Dirani, Elodie Bousquet, Min Zhao, Nicolette Farman, Frédéric Jaisser, Francine Behar-Cohen
Progress in Retinal and Eye Research.2015; 48: 82.     CrossRef
A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study
John D Pitcher, Andre J Witkin, Francis Char DeCroos, Allen C Ho
British Journal of Ophthalmology.2015; 99(6): 848.     CrossRef
Therapeutic benefit of melatonin in refractory central serous chorioretinopathy
A L Gramajo, G E Marquez, V E Torres, C P Juárez, R E Rosenstein, J D Luna
Eye.2015; 29(8): 1036.     CrossRef
Cytokine levels of the aqueous humour in central serous chorioretinopathy
Sang Hoon Jung, Kyung-A Kim, Sea Woon Sohn, Sung Jae Yang
Clinical and Experimental Optometry.2014; 97(3): 264.     CrossRef
Current concepts in managing central serous chorioretinopathy
Howard F. Fine, Michael D. Ober, Seenu M. Hariprasad
Ophthalmic Surgery, Lasers and Imaging Retina.2014; 45(1): 9.     CrossRef
Diagnosis and interventions for central serous chorioretinopathy: review and update
Godfrey Quin, Gerald Liew, I-Van Ho, Mark Gillies, Samantha Fraser-Bell
Clinical & Experimental Ophthalmology.2013; 41(2): 187.     CrossRef
Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review
Y-R Chung, E J Seo, H M Lew, K H Lee
Eye.2013; 27(12): 1339.     CrossRef
Central serous chorioretinopathy: a review of epidemiology and pathophysiology
Gerald Liew, Godfrey Quin, Mark Gillies, Samantha Fraser-Bell
Clinical & Experimental Ophthalmology.2013; 41(2): 201.     CrossRef
The Efficacy of Intravitreal Bevacizumab for Acute Central Serous Chorioretinopathy
Erdinc Aydin
Journal of Ocular Pharmacology and Therapeutics.2013; 29(1): 10.     CrossRef
The stress response as a target for treatment of central serous chorioretinopathy
Dhiren Bujarborua, Shyamanga Borooah, Baljean Dhillon
Expert Review of Ophthalmology.2013; 8(5): 457.     CrossRef
Central Serous Chorioretinopathy: Update on Pathophysiology and Treatment
Benjamin Nicholson, Jason Noble, Farzin Forooghian, Catherine Meyerle
Survey of Ophthalmology.2013; 58(2): 103.     CrossRef
Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy
M J Koss, I Beger, F H Koch
Eye.2012; 26(2): 307.     CrossRef
Behandlung der Retinopathia centralis serosa
I. Beger, M.J. Koss, F. Koch
Der Ophthalmologe.2012; 109(12): 1224.     CrossRef
LOW-DOSE METHOTREXATE FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
Shree K. Kurup, Armando Oliver, Andres Emanuelli, Vincent Hau, David Callanan
Retina.2012; 32(10): 2096.     CrossRef
Review and update of central serous chorioretinopathy
Alexander Ross, Adam H Ross, Quresh Mohamed
Current Opinion in Ophthalmology.2011; 22(3): 166.     CrossRef